sec filing
SH
NASDAQ · SHPH
Shuttle Pharmaceuticals Holdings, Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$4.00
Up+$0.01 (+0.25%)
Updated Sep 25, 2026, 10:50 PM
SID Score
5.7/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.88M
- P/E ratio
- -0.37
- Dividend yield
- 0.00%
- 52-week range
- $0.49 – $6.15
- Volume
- 48.87K
- Avg. volume
- 320.11K
Price performance
SHPH price history
1M range · 20 trading sessions · Daily adjusted prices
SHPH closed at $4.00 after 20 trading sessions, up 3.09% for the selected period.
- Last close
- $4.00
- Period change
- +3.09%
- Period low
- $3.13
- Period high
- $4.00
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 24, 2026 | $3.59 | $4.09 | $3.5001 | $4.00 | 48.87K |
| Sep 23, 2026 | $3.70 | $3.90 | $3.511 | $3.59 | 50.1K |
| Sep 22, 2026 | $3.41 | $4.10 | $3.32 | $3.76 | 87.76K |
| Sep 21, 2026 | $3.21 | $3.585 | $3.21 | $3.47 | 35.48K |
| Sep 18, 2026 | $3.315 | $3.505 | $3.21 | $3.21 | 24.34K |
| Sep 17, 2026 | $3.20 | $3.38 | $3.13 | $3.38 | 16.01K |
| Sep 16, 2026 | $3.62 | $3.62 | $3.125 | $3.13 | 25.89K |
| Sep 15, 2026 | $3.49 | $3.61 | $3.42 | $3.53 | 22.84K |
| Sep 14, 2026 | $3.50 | $3.5886 | $3.45 | $3.45 | 5.27K |
| Sep 11, 2026 | $3.53 | $3.55 | $3.46 | $3.53 | 10.92K |
| Sep 10, 2026 | $3.42 | $3.53 | $3.4181 | $3.53 | 16.02K |
| Sep 9, 2026 | $3.54 | $3.6188 | $3.4063 | $3.50 | 12.94K |
| Sep 8, 2026 | $3.48 | $3.6101 | $3.4245 | $3.54 | 10.99K |
| Sep 4, 2026 | $3.52 | $3.59 | $3.40 | $3.50 | 9.08K |
| Sep 3, 2026 | $3.50 | $3.565 | $3.4005 | $3.48 | 11.78K |
| Sep 2, 2026 | $3.59 | $3.65 | $3.42 | $3.49 | 24.57K |
| Sep 1, 2026 | $3.37 | $4.10 | $3.37 | $3.61 | 153.41K |
| Aug 31, 2026 | $3.50 | $3.62 | $3.36 | $3.36 | 51.99K |
| Aug 28, 2026 | $3.69 | $3.74 | $3.50 | $3.54 | 55.31K |
| Aug 27, 2026 | $3.75 | $3.99 | $3.6301 | $3.88 | 125.13K |
Latest SHPH news
The latest Smart Investors Daily articles mentioning SHPH.
Stock researchResearch & News · Competitors
Loading stock research…